Vascular endothelial dysfunction after anthracyclines treatment in children with acute lymphoblastic leukemia
- PMID: 23559975
- PMCID: PMC3611047
- DOI: 10.3345/kjp.2013.56.3.130
Vascular endothelial dysfunction after anthracyclines treatment in children with acute lymphoblastic leukemia
Abstract
Purpose: Anthracyclines have been utilized in the treatment of children with acute lymphoblastic leukemia (ALL). Recent studies have shown that anthracyclines may induce toxicity in the vascular endothelium. This study was performed using brachial artery reactivity (BAR) to evaluate vascular endothelial function in ALL patients who were treated with anthracycline chemotherapy.
Methods: We included 21 children with ALL who received anthracycline chemotherapy and 20 healthy children. The cumulative dose of anthracyclines in the ALL patients was 142.5±18.2/m(2). The last anthracycline dose was administered to the patients 2 to 85 months prior to their examination using BAR. The diameter of the brachial artery was measured in both groups using echocardiography, and BAR was calculated as the percentage change in the arterial diameter after release of the cuff relative to the baseline vessel diameter.
Results: In the anthracycline-treated group, BAR was observed to be 3.4%±3.9%, which was significantly lower than that observed in the control group (12.1%±8.0%, P<0.05). The time elapsed after the last anthracycline treatment and the age at the time of treatment did not affect the change in BAR (P=0.06 and P=0.13, respectively).
Conclusion: These results provided evidence that treatment of ALL patients with anthracycline results in endothelial dysfunction. A larger cohort study and a longer follow-up period will be required to clarify the relationship between endothelial dysfunction resulting from anthracycline treatment for childhood ALL and occurrence of cardiovascular diseases later in life.
Keywords: Acute lymphoblastic leukemia; Anthracycline; Child; Vascular endothelium.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures



Similar articles
-
Assessment of brachial artery reactivity, carotid intima-media thickness, and adhesion molecules in pediatric solid tumor patients treated with anthracyclines.Pediatr Hematol Oncol. 2016 Apr;33(3):178-85. doi: 10.3109/08880018.2016.1146375. Epub 2016 Mar 16. Pediatr Hematol Oncol. 2016. PMID: 26984313
-
Anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study.J Clin Oncol. 2006 Feb 20;24(6):925-8. doi: 10.1200/JCO.2005.03.5956. J Clin Oncol. 2006. PMID: 16484703
-
Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia.Pediatr Blood Cancer. 2007 Jun 15;48(7):663-7. doi: 10.1002/pbc.20313. Pediatr Blood Cancer. 2007. PMID: 17405151
-
Exposure to anthracyclines during childhood causes cardiac injury.Semin Oncol. 2006 Jun;33(3 Suppl 8):S8-14. doi: 10.1053/j.seminoncol.2006.04.019. Semin Oncol. 2006. PMID: 16781284 Review.
-
Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta-Analysis of Placebo Arms From Randomized Controlled Trials.J Am Heart Assoc. 2021 Mar 16;10(6):e018802. doi: 10.1161/JAHA.120.018802. Epub 2021 Mar 4. J Am Heart Assoc. 2021. PMID: 33660514 Free PMC article.
Cited by
-
Left Ventricular-Arterial Coupling and Vascular Function in Childhood Cancer Survivors Exposed to Anthracycline Chemotherapy.Rev Cardiovasc Med. 2023 Apr 23;24(4):124. doi: 10.31083/j.rcm2404124. eCollection 2023 Apr. Rev Cardiovasc Med. 2023. PMID: 39076269 Free PMC article.
-
Vascular toxic effects of cancer therapies.Nat Rev Cardiol. 2020 Aug;17(8):503-522. doi: 10.1038/s41569-020-0347-2. Epub 2020 Mar 26. Nat Rev Cardiol. 2020. PMID: 32218531 Free PMC article. Review.
-
Comparative Evaluation of Captopril, Spironolactone, and Carvedilol Effect on Endothelial Function in Breast Cancer Women Undergoing Chemotherapy.Adv Biomed Res. 2023 May 15;12:116. doi: 10.4103/abr.abr_81_21. eCollection 2023. Adv Biomed Res. 2023. PMID: 37434915 Free PMC article.
-
Non-invasive MR imaging techniques for measuring femoral arterial flow in a pediatric and adolescent cohort.Physiol Rep. 2022 May;10(10):e15182. doi: 10.14814/phy2.15182. Physiol Rep. 2022. PMID: 35614568 Free PMC article.
-
Cardiovascular ramifications of therapy-induced endothelial cell senescence in cancer survivors.Biochim Biophys Acta Mol Basis Dis. 2022 Apr 1;1868(4):166352. doi: 10.1016/j.bbadis.2022.166352. Epub 2022 Jan 15. Biochim Biophys Acta Mol Basis Dis. 2022. PMID: 35041996 Free PMC article. Review.
References
-
- Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354:166–178. - PubMed
-
- Bhatia S. Late effects among survivors of leukemia during childhood and adolescence. Blood Cells Mol Dis. 2003;31:84–92. - PubMed
-
- Hatzipantelis ES, Athanassiou-Metaxa M, Gombakis N, Tzimouli V, Taparkou A, Sidi-Fragandrea V, et al. Thrombomodulin and von Willebrand factor: relation to endothelial dysfunction and disease outcome in children with acute lymphoblastic leukemia. Acta Haematol. 2011;125:130–135. - PubMed
-
- Duquaine D, Hirsch GA, Chakrabarti A, Han Z, Kehrer C, Brook R, et al. Rapid-onset endothelial dysfunction with adriamycin: evidence for a dysfunctional nitric oxide synthase. Vasc Med. 2003;8:101–107. - PubMed
-
- Chow AY, Chin C, Dahl G, Rosenthal DN. Anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study. J Clin Oncol. 2006;24:925–928. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources